Molecure (WAR:MOC) Total Equity: zł89.43 Mil (As of Sep. 2025)


WAR:MOC Molecure SA WAR:MOC
29 GF Score
Price zł5.50
! 3 Warning Signs
View Full Analysis

What is Molecure Total Equity?

Molecure WAR:MOC +1.10% 29 Total Equity is zł89.43 Mil as of Sep. 2025. GuruFocus rates WAR:MOC with a GF Score™ of 29/100. The stock has 3 warning signs investors should review.

Molecure's total equity for the quarter that ended in Sep. 2025 was zł89.43 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Molecure Total Equity Historical Data

* Premium members only.

The historical data trend for Molecure's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Molecure Total Equity Chart

Molecure Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 147.09 141.14 126.45 100.93 103.41

Molecure Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 80.09 103.41 98.21 94.70 89.43
WAR:MOC
29GF Score
Molecure SA WAR:MOC
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Molecure Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Molecure's Total Equity for the fiscal year that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=113.721-10.314
=103.41

Molecure's Total Equity for the quarter that ended in Sep. 2025 is calculated as

Total Equity=Total Assets(Q: Sep. 2025 )-Total Liabilities(Q: Sep. 2025 )
=97.151-7.725
=89.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of zł89.43 Mil mean?
Molecure (WAR:MOC) has a Total Equity of zł89.43 Mil as of Sep. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Molecure and its competitors.
Is Molecure's Total Equity too high?
Molecure's current Total Equity is zł89.43 Mil. Overall, Molecure has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Molecure's Total Equity compare to VRTX and REGN?
Molecure's Total Equity of zł89.43 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Molecure and its competitors. Molecure's current Total Equity is zł89.43 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Molecure stock overvalued right now?
Molecure (WAR:MOC) has a current Total Equity of zł89.43 Mil. The current Total Equity is zł89.43 Mil. Molecure's overall GF Score™ is 29/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Molecure (WAR:MOC), the current Total Equity is zł89.43 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Molecure Business Description

Other Exchanges 1B1:Germany
Address Zwirki i Wigury 101, Warsaw, POL, 02-089
Molecure SA is a biopharmaceutical company engaged in discovering, developing, and commercializing novel therapeutics for neoplastic and inflammatory diseases. The company is focused on discovering and developing molecules with potential to become first-in-class or best-in-class drugs worldwide to treat unmet medical needs.
29GF Score

Get the complete analysis for WAR:MOC

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł5.50
Price